Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Work In Process (2023 - 2025)

Baird Medical Investment Holdings has reported Work In Process over the past 3 years, most recently at $200045.0 for Q4 2025.

  • For Q4 2025, Work In Process fell 13.16% year-over-year to $200045.0; the TTM value through Dec 2025 reached $200045.0, down 13.16%, while the annual FY2025 figure was $200045.0, 13.16% down from the prior year.
  • Work In Process for Q4 2025 was $200045.0 at Baird Medical Investment Holdings, down from $230355.0 in the prior quarter.
  • Over five years, Work In Process peaked at $313352.0 in Q4 2023 and troughed at $200045.0 in Q4 2025.
  • A 3-year average of $247917.3 and a median of $230355.0 in 2024 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: fell 26.49% in 2024 and later decreased 13.16% in 2025.
  • Year by year, Work In Process stood at $313352.0 in 2023, then dropped by 26.49% to $230355.0 in 2024, then dropped by 13.16% to $200045.0 in 2025.
  • Business Quant data shows Work In Process for BDMD at $200045.0 in Q4 2025, $230355.0 in Q4 2024, and $313352.0 in Q4 2023.